North America injectors Market Overview and Growth by 2027

The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027.

The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system Limitations. However, the North America injectors market is likely to have negative impact due to preference of alternative drug delivery.

In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of several chronic diseases. However, the majority of the available treatment options require parenteral drug administration, frequent dosing, and repeated hospital visits. Treatment administration via the parenteral route is associated with concerns such as dosing errors, microbial contamination risks, and needle stick injuries. These are found to be the primary factors affecting medication adherence and, thereby affecting significantly on therapeutic outcomes. Over the years, several companies have developed advanced therapeutic delivery solutions such as wearable autoinjectors and pen injectors to overcome the challenges associated with the administration of viscous and large molecule drugs. Moreover, the concept of self-injection reduces healthcare costs and allow the optimal usage of healthcare resources.

Wearable injectors present a robust solution for increasing dosing volumes and viscosities in non-clinical settings. Specifically, large volume wearable injectors are being used for subcutaneous drug delivery and have become a preferred choice for the administration of drugs in the home-care setting. Variants of these wearable devices have been designed to administer highly viscous drugs (such as biologics) in large volumes (more than 1 mL), offering numerous dosing options, integrated safety mechanisms, and minimum risk of needle stick injuries. Besides this, it is crucial to ensure safety of healthcare providers.

North America injectors market Revenue and Forecast to 2027 (US$ Mn)

North America injectors market – Market Segmentation

By Type

• On-body Injectors
• Off-body Injectors

By Application

• Diabetes
• Oncology
• Cardiovascular Disease
• Autoimmune Disease
• Other Applications

By End User

• Hospitals and Clinics
• Homecare Setting
• Other End User

By Country

• US
• Canada
• Mexico

Company Profiles

• BD
• CeQur SA
• Debiotech S.A
• E3D Elcam Drug Delivery Devices
• Insulet Corporation
• Gerresheimer AG
• Tandem Diabetes Care Inc
• Zealand Pharma A/S
• West Pharmaceutical Services, Inc
• Ypsomed AG
• Medtronic
• Amgen, Inc

North America injectors Report Scope